COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?

Area of Science:

• Infectious Diseases
• Vaccinology
• Bioethics

Background:

• The COVID-19 pandemic caused by SARS-CoV-2 has led to widespread death and societal disruption.
• Accelerating vaccine development is critical to controlling the pandemic.
• Human challenge studies offer a potential pathway to faster vaccine evaluation.

Purpose of the Study:

• To argue for the ethical justification of SARS-CoV-2 human challenge studies.
• To address concerns about scientific and ethical standards in vaccine research.
• To outline ethical considerations for conducting such studies.

Main Methods:

• Ethical analysis and argumentation.
• Review of principles for human challenge studies.
• Examination of informed consent requirements.

Main Results:

• The social value of accelerating SARS-CoV-2 vaccine development outweighs the risks associated with challenge studies.
• Human challenge studies can be conducted to high scientific and ethical standards.
• Specific information disclosure is necessary for informed consent.

Conclusions:

• SARS-CoV-2 human challenge studies are ethically justifiable and should be considered in the global research response.
• Addressing misperceptions and ensuring ethical conduct are key to their implementation.
• Informed consent processes must be transparent and comprehensive.